The Impact of Pre-, Pro- and Synbiotics Supplementation in Colorectal Cancer Treatment: a Systematic Review

Overview

Journal Front Oncol

Specialty Oncology

Date 2024 May 29

PMID 38807764

Authors

Mariana Melo Moreira

Marta Carrico

Manuel Luis Capelas

Nuno Pimenta

Teresa Santos

Susana Ganhao-Arranhado

Antti Makitie

Paula Ravasco

Affiliations

Soon will be listed here.

Abstract

Introduction: The effectiveness of the supplementation of prebiotics, probiotics and synbiotics as a therapeutic approach in colorectal cancer (CRC) remains unclear. The aim of this systematic review is to critically examine the current scientific evidence on the impact of modulating the microbiota, through the use of prebiotics, probiotics and synbiotics, in patients diagnosed with CRC undergoing treatment, to determine the potential therapeutic use of this approach.

Methods: This systematic review was made according to the PRISMA 2020 guidelines. Inclusion criteria were randomized controlled trials (RCT) comparing the impact of pre-, pro-, or synbiotic supplementation with placebo or standard care in patients with CRC undergoing treatment. Exclusion criteria were non-human studies, non-RCTs, and studies in languages other than English or Portuguese. Six databases were consulted, namely, Cochrane Library, Pubmed, Scopus, Cinahl, MedicLatina and Web of Science until May of 2023. RAYYAN software was used to manage the search results and risk of bias was assessed according to the guidelines of the Cochrane Collaboration using the Rob 2.0 tool.

Results: Twenty-four RCTs met the inclusion criteria and were included in this review. Administration of pre-, pro-, or synbiotics improved surgical outcomes such as the incidence of infectious and non-infectious postoperative complications, return to normal gut function, hospital length of stay, and antibiotic usage. The supplementation of these microorganisms also alleviated some symptoms from chemotherapy and radiotherapy, mainly diarrhea. Evidence on the best approach in terms of types of strains, dosage and duration of intervention is still scarce.

Conclusions: Pre-, pro-, and synbiotics supplementation appears to be a beneficial therapeutic approach in CRC treatment to improve surgical outcomes and to alleviate side-effects such as treatment toxicity. More RCTs with larger sample sizes and less heterogeneity are needed to confirm these potential benefits and to determine the best strains, dosage, and duration of administration in each situation.

Systematic Review Registration: https://www.crd.york.ac.uk/prospero, identifier CRD42023413958.

Citing Articles

Synergistic . complementary synbiotics: the complexity of discriminating synbiotic concepts using a exemplary study.

Kleerebezem M, Fuhren J Microbiome Res Rep. 2025; 3(4):46.

PMID: 39741951 PMC: 11684985. DOI: 10.20517/mrr.2024.48.

Overview of the Efficacy of Using Probiotics for Neurosurgical and Potential Neurosurgical Patients.

Fijan S, Smigoc T Microorganisms. 2024; 12(7).

PMID: 39065129 PMC: 11279057. DOI: 10.3390/microorganisms12071361.

References

Avuthu N, Guda C . Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer. Microbiol Spectr. 2022; 10(4):e0001322. PMC: 9431300. DOI: 10.1128/spectrum.00013-22. View

Theodoropoulos G, Memos N, Peitsidou K, Karantanos T, Spyropoulos B, Zografos G . Synbiotics and gastrointestinal function-related quality of life after elective colorectal cancer resection. Ann Gastroenterol. 2016; 29(1):56-62. PMC: 4700848. View

Madrigal-Matute J, Banon-Escandell S . Colorectal Cancer and Microbiota Modulation for Clinical Use. A Systematic Review. Nutr Cancer. 2022; 75(1):123-139. DOI: 10.1080/01635581.2022.2108468. View

Johdi N, Sukor N . Colorectal Cancer Immunotherapy: Options and Strategies. Front Immunol. 2020; 11:1624. PMC: 7530194. DOI: 10.3389/fimmu.2020.01624. View

Kotzampassi K, Stavrou G, Damoraki G, Georgitsi M, Basdanis G, Tsaousi G . A Four-Probiotics Regimen Reduces Postoperative Complications After Colorectal Surgery: A Randomized, Double-Blind, Placebo-Controlled Study. World J Surg. 2015; 39(11):2776-83. DOI: 10.1007/s00268-015-3071-z. View

Kvakova M, Kamlarova A, Stofilova J, Benetinova V, Bertkova I . Probiotics and postbiotics in colorectal cancer: Prevention and complementary therapy. World J Gastroenterol. 2022; 28(27):3370-3382. PMC: 9346452. DOI: 10.3748/wjg.v28.i27.3370. View

Wu W, Ouyang Y, Zheng P, Xu X, He C, Xie C . Research trends on the relationship between gut microbiota and colorectal cancer: A bibliometric analysis. Front Cell Infect Microbiol. 2023; 12:1027448. PMC: 9868464. DOI: 10.3389/fcimb.2022.1027448. View

Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag C, Laversanne M . Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023; 72(2):338-344. DOI: 10.1136/gutjnl-2022-327736. View

Horvat M, Krebs B, Potrc S, Ivanecz A, Kompan L . Preoperative synbiotic bowel conditioning for elective colorectal surgery. Wien Klin Wochenschr. 2010; 122 Suppl 2:26-30. DOI: 10.1007/s00508-010-1347-8. View

10.

Zhang L, Jin Q, Chai D, Kuang T, Li C, Guan Y . The correlation between probiotic use and outcomes of cancer patients treated with immune checkpoint inhibitors. Front Pharmacol. 2022; 13:937874. PMC: 9468893. DOI: 10.3389/fphar.2022.937874. View

11.

Zeng J, Ji Y, Liang B, Zhang G, Chen D, Zhu M . The effect of pro/synbiotics on postoperative infections in colorectal cancer patients: A systematic review and meta-analysis. Complement Ther Clin Pract. 2021; 43:101370. DOI: 10.1016/j.ctcp.2021.101370. View

12.

Xu Q, Xu P, Cen Y, Li W . Effects of preoperative oral administration of glucose solution combined with postoperative probiotics on inflammation and intestinal barrier function in patients after colorectal cancer surgery. Oncol Lett. 2019; 18(1):694-698. PMC: 6539823. DOI: 10.3892/ol.2019.10336. View

13.

Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I . Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229-263. DOI: 10.3322/caac.21834. View

14.

Zhang J, Du P, Gao J, Yang B, Fang W, Ying C . Preoperative probiotics decrease postoperative infectious complications of colorectal cancer. Am J Med Sci. 2011; 343(3):199-205. DOI: 10.1097/MAJ.0b013e31823aace6. View

15.

Pandey H, Tang D, Wong S, Lal D . Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities. Cancers (Basel). 2023; 15(3). PMC: 9913759. DOI: 10.3390/cancers15030866. View

16.

Dekker E, Tanis P, Vleugels J, Kasi P, Wallace M . Colorectal cancer. Lancet. 2019; 394(10207):1467-1480. DOI: 10.1016/S0140-6736(19)32319-0. View

17.

Frey-Furtado L, Magalhaes I, Azevedo M, Sampaio-Maia B . The Role of Biotics as a Therapeutic Strategy for Oral Mucositis - A Systematic Review. Probiotics Antimicrob Proteins. 2023; 16(4):1313-1326. PMC: 11322319. DOI: 10.1007/s12602-023-10116-z. View

18.

Rebersek M . Gut microbiome and its role in colorectal cancer. BMC Cancer. 2021; 21(1):1325. PMC: 8666072. DOI: 10.1186/s12885-021-09054-2. View

19.

Komatsu S, Sakamoto E, Norimizu S, Shingu Y, Asahara T, Nomoto K . Efficacy of perioperative synbiotics treatment for the prevention of surgical site infection after laparoscopic colorectal surgery: a randomized controlled trial. Surg Today. 2015; 46(4):479-90. DOI: 10.1007/s00595-015-1178-3. View

20.

Dikeocha I, Al-Kabsi A, Eid E, Hussin S, Alshawsh M . Probiotics supplementation in patients with colorectal cancer: a systematic review of randomized controlled trials. Nutr Rev. 2021; 80(1):22-49. DOI: 10.1093/nutrit/nuab006. View